메뉴 건너뛰기




Volumn 81, Issue 962, 2005, Pages 731-732

Standing at the crossroads: Which way will dementia services evolve?

Author keywords

[No Author keywords available]

Indexed keywords

AGE; BRAIN DYSFUNCTION; COST OF ILLNESS; DEMENTIA; EDITORIAL; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE NEED; HEALTH EDUCATION; HEALTH PROMOTION; HUMAN; LOWER CAMBRIAN; MEDICAL SERVICE; MENTAL HEALTH SERVICE; NATIONAL HEALTH SERVICE; PRIMARY MEDICAL CARE; PSYCHIATRIST; STAFF TRAINING; UNITED KINGDOM;

EID: 29244467378     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2005.033563     Document Type: Editorial
Times cited : (1)

References (5)
  • 2
    • 10044283107 scopus 로고    scopus 로고
    • Rivastigmine for dementia associated with Parkinson's disease
    • Emre M, Aarsland D, Albanese A, et al. Rivastigmine for dementia associated with Parkinson's disease. NEJM 2004;351:24.
    • (2004) NEJM , vol.351 , pp. 24
    • Emre, M.1    Aarsland, D.2    Albanese, A.3
  • 3
    • 0004073834 scopus 로고    scopus 로고
    • Alzheimers disease in the UK: Burden of disease and future care
    • London: Imperial College of Science and Technology
    • Bosenquet N, May J, Johnson N. Alzheimers disease in the UK: burden of disease and future care. Health Policy Review Number 12. London: Imperial College of Science and Technology, 1998.
    • (1998) Health Policy Review Number 12
    • Bosenquet, N.1    May, J.2    Johnson, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.